z-logo
Premium
The effectiveness of Botulinum Toxin A for treatment of upper limb impairments and dysfunctions in breast cancer survivors: A randomised controlled trial
Author(s) -
De Groef An,
Devoogdt Nele,
Van Kampen Marijke,
De Hertogh Laura,
Vergote Margot,
Geraerts Inge,
Dams Lore,
Van der Gucht Elien,
Debeer Philippe
Publication year - 2020
Publication title -
european journal of cancer care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.849
H-Index - 67
eISSN - 1365-2354
pISSN - 0961-5423
DOI - 10.1111/ecc.13175
Subject(s) - medicine , breast cancer , range of motion , upper limb , botulinum toxin , placebo , randomized controlled trial , physical therapy , dash , infiltration (hvac) , physical medicine and rehabilitation , surgery , cancer , alternative medicine , pathology , computer science , thermodynamics , operating system , physics
Objective To examine the effectiveness of a single Botulinum Toxin A (BTX‐A) infiltration in the pectoralis major muscle, in addition to a standard physical therapy (PT) programme on upper limb impairments and dysfunctions after breast cancer treatment. Methods Fifty breast cancer patients with persistent pain 3 months after finishing treatment participated in a double‐blinded randomised controlled trial. The intervention group received a single BTX‐A infiltration. The control group received a placebo (saline) infiltration. Within one week after the infiltration, all patients attended an individual PT programme (12 sessions) during the first 3 months. Outcome parameters were active shoulder range of motion, upper limb strength, scapular statics and shoulder function. Measures were taken before the intervention, at 1, 3 (i.e. after the intervention) and 6 months follow‐up. Results No differences between groups were found for all outcome parameters over the course of 6 months. However, overall beneficial effects of the PT for active forward flexion shoulder range of motion and shoulder function were found in both groups. Conclusion A single Botulinum Toxin A (BTX‐A) infiltration in the pectoralis major muscle, in addition to a PT programme cannot be recommended to treat upper limb impairments and dysfunctions after breast cancer treatment.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here